Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
02.10. | Scorpius Holdings, Inc.: Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats | 8 | GlobeNewswire (Europe) | DURHAM, N.C., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) ("Scorpius" or "the Company"), an integrated contract development and manufacturing organization ("CDMO")... ► Artikel lesen | |
02.10. | Ero Copper Corp.: Ero Copper Announces Initial NI 43-101 Mineral Resource Estimate for the Furnas Copper-Gold Project | 143 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) ("Ero" or the "Company") is pleased to announce an initial National Instrument 43-101 ("NI 43-101")... ► Artikel lesen | |
02.10. | NOVAGOLD RESOURCES INC.: NOVAGOLD Reports Third Quarter 2024 Financial Results | 183 | GlobeNewswire (Europe) | Focused on Progressing the Donlin Gold Project to a Fully Updated Feasibility Study Wide-Ranging Community Involvement and Government Engagement to Sustain Donlin Gold's Social License Strong... ► Artikel lesen | |
02.10. | Innventure, Inc.: Innventure LLC and Learn CW Investment Corporation Announce Closing of Business Combination | 102 | GlobeNewswire (Europe) | ORLANDO, Fla., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Innventure, Inc. (Nasdaq: INV) and Learn CW Investment Corporation (NASDAQ: LCW) ("Learn CW"), a special purpose acquisition company, today announced... ► Artikel lesen | |
02.10. | Spero Therapeutics, Inc.: Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy | 106 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments... ► Artikel lesen | |
02.10. | Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 71 | GlobeNewswire (Europe) | SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ("Olema" or "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development... ► Artikel lesen | |
02.10. | Silynxcom Ltd.: Silynxcom Announces Results for First Half of 2024; Significant Revenue Growth and Improvement in Gross Margin | 88 | GlobeNewswire (Europe) | NETANYA, Israel, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE American: SYNX) ("Silynxcom" or the "Company"), a manufacturer and developer of ruggedized tactical communication headset devices... ► Artikel lesen | |
02.10. | Xilio Therapeutics, Inc.: Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 81 | GlobeNewswire (Europe) | WALTHAM, Mass., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies... ► Artikel lesen | |
02.10. | Mural Oncology, Inc.: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 70 | GlobeNewswire (Europe) | WALTHAM, Mass. and DUBLIN, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies... ► Artikel lesen | |
02.10. | Solid Biosciences Inc.: Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 87 | GlobeNewswire (Europe) | CHARLESTOWN, Mass., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company"), a life sciences company developing precision genetic medicines for neuromuscular and cardiac... ► Artikel lesen | |
02.10. | BigCommerce Holdings, Inc.: BigCommerce Appoints Travis Hess as CEO | 141 | GlobeNewswire (Europe) | AUSTIN, Texas, Oct. 02, 2024 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. ("BigCommerce") (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B... ► Artikel lesen | |
02.10. | Gatos Silver, Inc.: Gatos Silver Reports Positive Third Quarter Exploration Results Including Mineralized Intercepts on the Central Deeps Target at Cerro Los Gatos | 185 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Gatos Silver, Inc. (NYSE/TSX: GATO) ("Gatos Silver" or the "Company") today provided an update on the drilling and exploration programs... ► Artikel lesen | |
02.10. | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 188 | GlobeNewswire (Europe) | BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on September 30... ► Artikel lesen | |
02.10. | Range Impact, Inc.: Range Impact Announces Sale of Cannabinoid Drug Development Business | 89 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to improving the health and wellness of people and the... ► Artikel lesen | |
02.10. | Processa Pharmaceuticals, Inc.: Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer | 89 | GlobeNewswire (Europe) | Phase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabineResults from this Phase 2 trial will evaluate NGC-Cap's safety-efficacy profile and help to define... ► Artikel lesen | |
02.10. | Fate Therapeutics, Inc.: Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | 141 | GlobeNewswire (Europe) | SAN DIEGO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent... ► Artikel lesen | |
02.10. | Osisko Mining Inc.: ISS and Glass Lewis Recommend Osisko Shareholders Vote for the Plan of Arrangement With Gold Fields | 161 | GlobeNewswire (Europe) | Osisko Mining Board of Directors Unanimously Recommends that Shareholders vote FOR the Arrangement Shareholders Are Reminded to Vote Prior to October 15, 2024 Proxy Submission Deadline TORONTO, Oct.... ► Artikel lesen | |
02.10. | Valoe Oyj: The Administrator Applies for Suspension of Valoe's Restructuring Proceedings. Valoe Continues Its Financing Negotiations. | 205 | GlobeNewswire (Europe) | Valoe Corporation Inside information 2 October 2024 at 21.15 Finnish time On 2 October 2024, Valoe Corporation's ("Company" or "Valoe") administrator, Mr Pekka Jaatinen, Attorney,... ► Artikel lesen | |
02.10. | Groupe Casino: Store disposals | 156 | GlobeNewswire (Europe) | Casino Group completes two waves of store disposals Paris, 2 October 2024 Following the agreements reached on 26 May 2023, Casino Group announces that it has sold its controlling 51% stake in 60... ► Artikel lesen | |
02.10. | Wyld Networks AB: Report from the Extraordinary General Meeting in Wyld Networks AB | 52 | GlobeNewswire (Europe) | The Extraordinary General Meeting in Wyld Networks AB ("Wyld Networks" or the "Company") was held today, 2 October 2024, whereby the shareholders passed the following resolutions.
Approval of the... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
SUPER MICRO COMPUTER | 2.941 |
EVOTEC | 2.190 |
TUI | 1.876 |
BAYER | 1.809 |
NVIDIA | 1.697 |
NEL | 1.305 |
RENK GROUP | 1.160 |
RHEINMETALL | 1.058 |
TESLA | 886 |
PALANTIR TECHNOLOGIES | 839 |
DEUTSCHE BANK | 787 |
VOLKSWAGEN | 768 |
MICROSTRATEGY | 726 |
BYD | 708 |
PLUG POWER | 674 |
COMMERZBANK | 668 |
BASF | 645 |
JINKOSOLAR | 621 |
MERCEDES-BENZ | 603 |
AMAZON | 588 |
DEUTSCHE TELEKOM | 568 |
INTEL | 559 |
BMW | 557 |
ALLIANZ | 547 |
THYSSENKRUPP | 546 |